Status:
COMPLETED
Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
Multiple Ascending Dose Study
Eligibility Criteria
Inclusion
- Provision of Informed Consent
- Healthy male subjects and female subjects (of non-child bearing potential)
- with suitable veins for cannulation or repeated venipuncture
Exclusion
- Inability to understand or cooperate with given information
- Any positive result on screening for human immune deficiency virus (HIV), Hepatitis B, or Hepatitis C test
- History of seizure (including infancy febrile seizures) or family history of seizure
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00861718
Start Date
April 1 2009
End Date
October 1 2009
Last Update
December 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Philadelphia, Pennsylvania, United States